Psyence Group Advances Psilocybin Clinical Trial TipRankssource Post navigation Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial – Financial PostDoctor issues warning after testing mushroom gummies sold in Virgina stores: 'It's the Wild West of right now' – CBS 6 News Richmond WTVR